• Feedback
  • RSS Feed
  • Sitemap
Odisha News, Odisha Breaking News, Odisha Latest News || Ommcom News
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
Odisha News, Odisha Breaking News, Odisha Latest News || Ommcom News
Home World

Finnish Researchers Develop New Genetic Test To Improve Ovarian Cancer Treatment

OMMCOM NEWS by OMMCOM NEWS
January 12, 2023
in World

Helsinki: A new genetic test developed at the University of Helsinki and Helsinki University Hospital helps identify ovarian cancer patients who benefit from PARP inhibitors, a type of targeted drug that could be effective against ovarian cancer, the University of Helsinki said in a statement.

In recent years, PARP inhibitors have achieved excellent results as a maintenance treatment after surgery and cytostatic therapy of newly diagnosed ovarian cancer patients.

Since the therapy with PARP inhibitors is associated with potentially serious side effects, it is important to be able to target it to the patients that benefit the most from it, the university added on Wednesday.

“The genetic test helps to identify patients who do not benefit from the drug, thus avoiding unnecessary treatment and the adverse effects associated with the drug,” Anniina Farkkila from Helsinki University Hospital was quoted as saying in the statement.

The new genetic test has been developed with the help of artificial intelligence (AI), machine learning and statistics, Xinhua news agency reported.

“Roughly half of ovarian cancers have a deficiency in a specific DNA (deoxyribonucleic acid) repair pathway. Cancer cells with this deficiency are unable to accurately repair breaks in the DNA double-strand, which causes the accumulation of DNA lesions,” doctoral researcher Fernando Perez-Villatoro from the University of Helsinki said.

The study results show that each cancer type is associated with different characteristics of the genetic lesions related to homologous recombination DNA-repair deficiency (HRD), which is a common driver of genomic instability. Therefore, developing a test optimised for ovarian cancer was important for advancing the precision of therapies for the cancer type, the University of Helsinki noted.

The study results were published in the latest issue of npj Precision Oncology.

(IANS)

ShareTweetSendSharePinShareSend
Previous Post

Iran Sentences Ex-Official To Death Over ‘Spying For Britain’

Next Post

Thousands Of Nurses Go On Strike For 3rd Day In New York City

Related Posts

First Buddhist Chief Justice
World

Lankan Lawyers Extend Wishes To First Buddhist Chief Justice Of India

May 16, 2025
Former PM Masra
World

Chad’s Former PM Masra Arrested For ‘Inciting Hatred’

May 16, 2025
South Korea
World

South Korea Requests Exemption From All US Tariffs

May 16, 2025
Indian Constitution
World

New York State Senate Adopts Resolution Celebrating 75th Anniversary Of Indian Constitution

May 16, 2025
World

Pakistan Deputy PM Draws Flak After Citing Fake Image To Praise PAF In Parliament

May 16, 2025
World

‘In World On Fire, Buddha’s Teachings Hold Key To Answers’

May 16, 2025
Next Post

Thousands Of Nurses Go On Strike For 3rd Day In New York City

Scientists Discover Remains Of Four New Dinosaur Species In Chile: Report

US Researchers Eye Developing Mucosal Vaccines For Respiratory Viruses

Khimji
TPCODL
  • Feedback
  • RSS Feed
  • Sitemap

© 2025 - Ommcom News. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

© 2025 - Ommcom News. All Rights Reserved.